nach oben

AIDS and Behavior

Erschienen in:

01.04.2010 | Original Paper

Anxiety and Depression Symptoms as Risk Factors for Non-adherence to Antiretroviral Therapy in Brazil

verfasst von: Lorenza Nogueira Campos, Mark Drew Crosland Guimarães, Robert H. Remien

Erschienen in: AIDS and Behavior | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Depression and anxiety are common among HIV-infected people and rank among the strongest predictors of non-adherence to antiretroviral therapy (ART). This longitudinal study aimed to assess whether symptoms of anxiety and depression are predictors of non-adherence among patients initiating ART at two public referral centers (n = 293) in Belo Horizonte, Brazil. Prevalence of severe anxiety and depression symptoms before starting ART was 12.6% and 5.8%, respectively. Severe anxiety was a predictor of non-adherence to ART during follow-up period (RH = 1.87; 95% CI = 1.14–3.06) adjusted for low education, unemployment, alcohol use in the last month and symptoms of AIDS; while a history of injection drug use had borderline statistical significance with non-adherence. These findings suggest that using a brief screening procedure to assess anxiety and depression symptoms before initiating ART help identify individuals for interventions to improve adherence and quality of life.

Acurcio, F. A., Puig-Junoy, J., Bonolo, P. F., Ceccato, M. G. B., & Guimarães, M. D. C. (2006). Cost-effectiveness of initial adherence to antiretroviral therapy among HIV infected patients in Belo Horizonte, Brazil. Revista Espanola de Salud Publica, 80, 41–54. doi:10.1590/S1135-57272006000100005.

Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., et al. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394–402. doi:10.1176/appi.psy.45.5.394.CrossRefPubMed

Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2002). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423. doi:10.1086/323201.CrossRef

Au, A., Chan, I., Li, P., Chung, R., Po, L. M., & Yu, P. (2004). Stress and health-related quality of life among HIV-infected persons in Hong Kong. AIDS and Behavior, 8, 119–129. doi:10.1023/B:AIBE.0000030243.50415.c0.CrossRefPubMed

Barfod, T. S., Gerstoft, J., Rodkjaer, L., Pedersen, C., Nielsen, H., Moller, A., et al. (2005). Patient’s answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: A cross-sectional survey. AIDS Patient Care and STDs, 19, 317–325. doi:10.1089/apc.2005.19.317.CrossRefPubMed

Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale: An update literature review. Journal of Psychosomatic Research, 52, 69–77. doi:10.1016/S0022-3999(01)00296-3.CrossRefPubMed

Blanco, J. M. S., Pérez, I. R., Lima, A. O. L., Recio, J. M. C., López, E. G., & Lasanta, J. J. A. (2005). Adherent to antiretroviral treatment in prisons. AIDS Research and Human Retroviruses, 21, 683–688. doi:10.1089/aid.2005.21.683.CrossRefPubMed

Bonolo, P. F., César, C. C., Acúrcio, F. A., Ceccato, M. G. B., Pádua, C. A. M., Álvares, J., et al. (2005). Non-adherence among patients initiating antiretroviral therapy: A challenge for health professionals in Brazil. AIDS (London, England), 19, S5–S13. doi:10.1097/01.aids.0000191484.84661.2b.

Botega, N. J., Bio, M. R., Zomignani, M. A., Garcia, C., & Pereira, W. A. B. (1995). Mood disorders among medical in-patients: A validation study of the hospital anxiety and depression scale (HAD). Journal of Public Health, 29, 355–363.PubMed

Botega, N. J., Pondé, M. P., Medeiros, P., Lima, M. G., & Guerreiro, C. A. M. (1998). Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epilépticos ambulatoriais. Jornal Brasileiro de Psiquiatria, 47, 285–289.

Braithwaite, R. S., Mcginnis, K. A., Conigliaro, J., Maisto, S. A., Crystal, S., Day, N., et al. (2005). A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism, Clinical and Experimental Research, 29, 1190–1197. doi:10.1097/01.ALC.0000171937.87731.28.CrossRefPubMed

Brasil, Ministério da Saúde. (2000). Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV. Brasília: Ministério da Saúde.

Brasil, Ministério da Saúde. (2008). UNGASS. Resposta brasileira 2005/2007. Relatório de progresso do país. Brasília: Ministério da Saúde.

Campos, L. N., Bonolo, P. F., & Guimarães, M. D. C. (2006). Anxiety and depression assessment prior to initiating antiretroviral treatment in Brazil. AIDS Care, 18, 529–536. doi:10.1080/09540120500221704.CrossRef

Carballo, E., Cadarso-Suárez, C., Carrera, I., Fraga, J., De La Fuente, J., Ocampo, A., et al. (2004). Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Quality of Life Research, 13, 587–599. doi:10.1023/B:QURE.0000021315.93360.8b.CrossRefPubMed

Carrieri, M. P., Raffi, F., Lewden, C., Sobel, A., Michelet, C., Cailleton, V., et al. (2003). Impact of early versus late-adherence to highly active antiretroviral therapy on immuno-virological response: A 3-year follow-up study. Antiviral Therapy, 8, 585–594.PubMed

Carvalho, C. V., Duarte, D. B., Merchán-Hamann, E., Bicudo, E., & Laguardia, J. (2003). Predictors of compliance with highly active antiretroviral therapy in Brasília, Distrito Federal, Brazil, 1999–2000. Reports in Public Health, 19, 593–604.

Centers for Disease Control and Prevention. (1992). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR, 41(RR-17), 1–19.

Chesney, M. (2004). Adherence to HAART regimens. In J. Laurence (Ed.), Medication adherence in HIV/AIDS (pp. 17–25). Larchmont: Mary Ann Liebert.

Cohen, M., Hoffman, R. G., Cromwell, C., Schmeidler, J., Ebrahim, F., Carrera, G., et al. (2002). The prevalence of distress in persons with Human Immunodeficiency Virus infection. Psychosomatics, 43, 10–15. doi:10.1176/appi.psy.43.1.10.CrossRefPubMed

Cook, R. L., Sereika, S. M., Hunt, S. C., et al. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83–88. doi:10.1111/j.1525-1497.2001.00122.x.CrossRefPubMed

Cove, J., & Petrak, J. (2004). Factors associated with sexual problems in HIV-positive gay men. International Journal of STD & AIDS, 15, 732–736. doi:10.1258/0956462042395221.CrossRef

Cox, D. R., & Oakes, D. (1984). Analysis of survival data. New York: Chapman and Hall.

Crawford, J. R., Henry, J. D., Crombie, C., & Taylor, E. P. (2001). Brief report. Normative data for the HADS from a large non-clinical sample. The British Journal of Clinical Psychology, 40, 429–434. doi:10.1348/014466501163904.CrossRefPubMed

Evans, D. L., Ten Have, T. R., Douglas, S. D., Gettes, D. R., Morrison, M., Chiappini, M. S., et al. (2002). Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. The American Journal of Psychiatry, 159, 752–759. doi:10.1176/appi.ajp. 159.10.1752.CrossRef

Falagas, M. E., Zarkadoulia, E. A., Pliatsika, P. A., & Panos, G. (2008). Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: A systematic review of the literature. Retroviroloy, 5, 13. doi:10.1186/1742-4690-5-13.CrossRef

Ford, J. D., Trestman, R. L., Steiberg, K., Tennen, H., & Allen, S. (2004). Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care. Social Science and Medicine, 58, 2145–2148. doi:10.1016/j.socscimed.2003.08.017.CrossRefPubMed

Freitas, G. V. S., & Botega, N. J. (2002). Gravidez na adolescência: prevalência de depressão, ansiedade e ideação suicida. Revista da Associação Médica Brasileira, 48, 245–249.CrossRefPubMed

Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386–395.PubMed

Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS (London, England), 13, 1099–1107. doi:10.1097/00002030-199906180-00014.

Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale: A review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17–41. doi:10.1016/S0022-3999(96)00216-4.CrossRefPubMed

Hosmer, D. W., & Lemeshow, S. (1999). Applied survival analysis: Regression modeling of time to event data. New York: Wiley.

Lambert, S., Keegan, A., & Petrak, J. (2005). Sex and relationships for HIV positive women since HAART: A quantitative study. Sexually Transmitted Infections, 81, 333–337. doi:10.1136/sti.2004.013516.CrossRefPubMed

Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (London, England), 16, 767–774. doi:10.1097/00002030-200203290-00012.

Mantel, N. (1963). Chi-square tests with one degree of freedom: Extensions of the Mantel–Haenszel procedure. Journal of the American Statistical Association, 58, 690–700. doi:10.2307/2282717.CrossRef

Mendes, M. F., Tilbery, C. P., Balsimelli, S., Moreira, M. A., & Barão-Cruz, A. M. (2003). Depressão na esclerose múltipla forma remitente-recorrente. Arquivos de Neuro-Psiquiatria, 61, 591–595. doi:10.1590/S0004-282X2003000400012.CrossRefPubMed

Melo, A. P. S., & Guimarães, M. D. C. (2005). Factors associated with psychiatric treatment dropout in a mental health reference center, Belo Horizonte. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil: 1999), 27, 113–118. doi:10.1590/S1516-44462005000200008.

Miller, N. H. (1997). Compliance with treatment regimens in chronic asymptomatic diseases. The American Journal of Medicine, 102, 4–49. doi:10.1016/S0002-9343(97)00467-1.CrossRef

Molassiotis, A., Nahas-Lopez, V., Chung, W. Y. R., Lam, S. W. C., Li, C. K. P., & Lau, T. F. J. (2002). Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD and AIDS, 13, 301–310. doi:10.1258/0956462021925117.CrossRefPubMed

Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D., et al. (2000). Patient-reported non-adherence to HAART is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndromes, 24, 123–128.PubMed

Nemes, M. I. B., Carvalho, H. B., & Souza, M. F. M. (2004). Antiretroviral therapy adherence in Brazil. AIDS (London, England), 18, S15–S20. doi:10.1097/00002030-200406003-00004.

Nieuwkerk, M. A., & Oort, F. J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response. A meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 38, 445–448. doi:10.1097/01.qai.0000147522.34369.12.CrossRefPubMed

Olsson, I., Kykletun, A., & Dahl, A. (2005). The hospital anxiety and depression rating scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry, 5, 46. doi:10.1186/1471-244X-5-46.CrossRefPubMed

Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed

Pence, B. W., Miller, W. C., Gaynes, B. N., & Eron, J. J. (2007). Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 44, 159–166. doi:10.1097/QAI.0b013e31802c2f51.CrossRef

Pinheiro, C. A. T., De-Carvalho-Leite, J. C., Drachler, M. L., & Silveira, V. L. (2002). Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: A cross-sectional study in Southern Brazil. Brazilian Journal of Medical and Biological Research, 35, 1173–1181.PubMed

Rodrigues-Júnior, A. L., & Castilho, E. A. (2004). A epidemia de AIDS no Brasil, 1991–2000: descrição espaço-temporal. Revista da Sociedade Brasileira de Medicina Tropical, 37, 312–317.CrossRefPubMed

Santos, F. R. M., Kozasa, E. H., Chauffaille, M. L. L. F., Colleoni, G. W. B., & Leite, J. R. (2006). Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies. Journal of Psychosomatic Research, 60, 505–511. doi:10.1016/j.jpsychores.2005.08.017.CrossRefPubMed

Simoni, J. M., Kurth, A. E., Pearson, C. R., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245. doi:10.1007/s10461-006-9078-6.CrossRefPubMed

Spire, B., Duran, S., Souville, M., Leport, C., Raffi, F., & Moatti, J. P. (2002). Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Social Science and Medicine, 54, 1481–1496. doi:10.1016/S0277-9536(01)00125-3.CrossRefPubMed

Tostes, M. A., Chalub, M., & Botega, N. J. (2004). The quality of life of HIV-infected women is associated with psychiatric morbidity. AIDS Care, 16, 177–186. doi:10.1080/09540120410001641020.CrossRefPubMed

Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of non-adherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine, 114, 573–580. doi:10.1016/S0002-9343(03)00093-7.CrossRefPubMed

Tucker, J. S., Orlando, M., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2004). Psychosocial mediators of antiretroviral non-adherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23, 363–370. doi:10.1037/0278-6133.23.4.363.CrossRefPubMed

Turner, B. J. (2002). Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. The Journal of Infectious Diseases, 185, S143–S151. doi:10.1086/340197.CrossRefPubMed

Wagner, G., & Miller, L. G. (2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndrome, 35, 203–204. doi:10.1097/00126334-200402010-00016.CrossRef

Wolf, M. S., Davis, T. C., Arozullah, A., Penn, R., Arnold, C., Sugar, M., et al. (2005). Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care, 17, 863–873.PubMed

World Health Organization. (2001). Adherence to long-term therapies: Policy for action. Geneva: World Health Organization.

World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization.

Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 370–376. doi:10.1111/j.1600-0447.1983.tb09716.x.CrossRef

Titel: Anxiety and Depression Symptoms as Risk Factors for Non-adherence to Antiretroviral Therapy in Brazil
verfasst von: Lorenza Nogueira Campos
Mark Drew Crosland Guimarães
Robert H. Remien
Publikationsdatum: 01.04.2010
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 2/2010
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-008-9435-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2010

HIV-Infected Prison Inmates: Depression and Implications for Release Back to Communities

Mental Health Considerations in Secondary HIV Prevention

Still Crazy After All These Years: The Challenge of AIDS Denialism for Science

Stress Biomarkers as Outcomes for HIV+ Prevention: Participation, Feasibility and Findings Among HIV+ Latina and African American Mothers

AIDS Denialism and Public Health Practice